NeoGenomics, Inc. Purchase Obligation, to be Paid, Year One
NeoGenomics, Inc. (NEO) had Purchase Obligation, to be Paid, Year One of $5.31 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity
us-gaap:PurchaseObligationDueInNextTwelveMonths · last filed 2026-02-17
- 2025-12-31: Purchase Obligation, to be Paid, Year One $5.31M.
- 2024-12-31: Purchase Obligation, to be Paid, Year One $782.00K.
- 2023-12-31: Purchase Obligation, to be Paid, Year One $2.17M.
- 2021-12-31: Purchase Obligation, to be Paid, Year One $1.00M.
| Period end | Purchase Obligation, to be Paid, Year One |
|---|---|
| 2025-12-31 | $5.31M 10-K · filed 2026-02-17 |
| 2024-12-31 | $782.00K 10-K · filed 2025-02-18 |
| 2023-12-31 | $2.17M 10-K · filed 2024-02-20 |
| 2021-12-31 | $1.00M 10-K · filed 2022-02-25 |
| 2020-12-31 | $6.77M 10-K · filed 2021-02-25 |
| 2019-12-31 | $7.36M 10-K · filed 2020-02-28 |
| 2018-12-31 | $220.00K 10-K · filed 2019-02-26 |
| 2017-12-31 | $942.00K 10-K · filed 2018-03-13 |
| 2016-12-31 | $1.29M 10-K · filed 2017-03-14 |
| 2015-12-31 | $2.54M 10-K · filed 2016-04-18 |
| 2014-12-31 | $301.00K 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |